Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
22K characters. Original on sec.gov ·
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
You should read the following discussion in conjunction with Management's Discussion and Analysis of Financial Conditions and Results of Operations included in our Annual Report for the year ended December 31, 2012 as filed on February 25, 2013 with the SEC and the notes to our Condensed Consolidated Financial Statements included elsewhere in this report.
Information About Forward-Looking Statements
This report includes "forward-looking statements" within the meaning of the federal securities laws. In addition, we, or our executive officers on our behalf, may from time to time make forward-looking statements in reports and other documents we file with the U.S. Securities and Exchange Commission ("SEC") or in connection with oral statements made to the press, potential investors or others. All statements that are not historical facts are "forward-looking statements." Forward-looking statements may be indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "believes" or "intends" and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in any forward-looking statement.
Examples of forward-looking statements in this report include but are not limited to statements regarding operating results, the success of our internal operating plans, our expectations regarding our ability to generate operating cash flows and reduce debt and associated interest expense, profit and cash flow expectations, the prospects for newly acquired businesses to be integrated and contribute to future growth and our expectations regarding growth through acquisitions. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the cost, timing and success of product upgrades and new product introductions, raw materials costs, expected pricing levels, the timing and cost of expected capital expenditures, expected outcomes of pending litigation, competitive conditions, general economic conditions and expected synergies relating to acquisitions, joint ventures and alliances. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the forward-looking statements are reasonable, our expectations may prove to be incorrect. Important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include, but are not limited to:
| · | general economic conditions; |
|---|
| · | difficulty making acquisitions and successfully integrating acquired businesses; |
|---|
| · | any unforeseen liabilities associated with future acquisitions; |
|---|
| · | limitations on our business imposed by our indebtedness; |
|---|
| · | unfavorable changes in foreign exchange rates; |
|---|
| · | difficulties associated with exports; |
|---|
| · | risks and costs associated with our international sales and operations; |
|---|
| · | increased directors' and officers' liability and other insurance costs; |
|---|
| · | risk of rising interest rates; |
|---|
| · | product liability and insurance risks; |
|---|
| · | increased warranty exposure; |
|---|
| · | future competition; |
|---|
| · | the cyclical nature of some of our markets; |
|---|
| · | reduction of business with large customers; |
|---|
| · | risks associated with government contracts; |
|---|
| · | changes in the supply of, or price for, raw materials, parts and components; |
|---|
| · | environmental compliance costs and liabilities; |
|---|
| · | risks and costs associated with asbestos-related litigation; |
|---|
| · | potential write-offs of our substantial goodwill and other intangible assets; |
|---|
| · | our ability to successfully develop new products; |
|---|
| · | failure to protect our intellectual property; |
|---|
| · | the effect of, or change in, government regulations (including tax); |
|---|
| · | economic disruption caused by terrorist attacks, health crises or other unforeseen events; and |
|---|
| · | the factors discussed in other reports filed with the SEC. |
|---|
We believe these forward-looking statements are reasonable; however, you should not place undue reliance on any forward-looking statements, which are based on current expectations. Further, forward-looking statements speak only as of the date they are made, and we undertake no obligation to publicly update any of these statements in light of new information or future events.
Overview
Roper Industries, Inc. ("Roper," "we" or "us") is a diversified growth company that designs, manufactures and distributes radio frequency ("RF") products, services and application software, industrial technology products, energy systems and controls and medical and scientific imaging products and software. We market these products and services to a broad range of markets, including RF applications, medical, water, energy, research, education, software-as-a-service ("SaaS")-based information networks, security and other niche markets.
We pursue consistent and sustainable growth in earnings by emphasizing continuous improvement in the operating performance of our existing businesses and by acquiring other carefully selected businesses that offer high value-added services, engineered products and solutions and are capable of achieving growth and maintaining high margins. Our acquisitions have represented both financial bolt-ons and new strategic platforms. We strive for high cash and earnings returns from our investments.
Critical Accounting Policies
There were no material changes during the quarter ended March 31, 2013 to the items that we disclosed as our critical accounting policies and estimates in "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2012 Annual Report on Form 10-K filed on February 25, 2013.
Recently Issued Accounting Standards
Information regarding new accounting pronouncements is included in Note 2 of the notes to Condensed Consolidated Financial Statements.
Results of Operations
General
The following tables set forth selected information for the periods indicated. Dollar amounts are in thousands and percentages are the particular line item shown as a percentage of net sales. Percentages may not foot due to rounding.
| Three months ended March 31, | |||||||
|---|---|---|---|---|---|---|---|
| 2013 | 2012 | ||||||
| Net sales: | |||||||
| Industrial Technology | $ | 182,239 | $ | 195,136 | |||
| Energy Systems & Controls | 145,642 | 148,602 | |||||
| Medical & Scientific Imaging | 200,444 | 162,811 | |||||
| RF Technology | 208,810 | 204,517 | |||||
| Total | $ | 737,135 | $ | 711,066 | |||
| Gross profit: | |||||||
| Industrial Technology | 51.2 | % | 50.6 | % | |||
| Energy Systems & Controls | 55.6 | % | 54.1 | % | |||
| Medical & Scientific Imaging | 67.3 | % | 65.2 | % | |||
| RF Technology | 53.9 | % | 51.8 | % | |||
| Total | 57.2 | % | 55.0 | % | |||
| Selling, general & administrative expenses: | |||||||
| Industrial Technology | 22.2 | % | 21.1 | % | |||
| Energy Systems & Controls | 31.0 | 30.1 | |||||
| Medical & Scientific Imaging | 37.4 | 38.6 | |||||
| RF Technology | 26.8 | 27.2 | |||||
| Total | 29.4 | 28.7 | |||||
| Segment operating profit: | |||||||
| Industrial Technology | 29.1 | % | 29.5 | % | |||
| Energy Systems & Controls | 24.5 | 24.0 | |||||
| Medical & Scientific Imaging | 29.9 | 26.6 | |||||
| RF Technology | 27.1 | 24.6 | |||||
| Total | 27.8 | 26.3 | |||||
| Corporate administrative expenses | (2.7 | ) | (2.3 | ) | |||
| 25.1 | 24.0 | ||||||
| Interest expense | (2.8 | ) | (2.2 | ) | |||
| Other expense | (0.3 | ) | (0.1 | ) | |||
| Earnings before income taxes | 22.0 | 21.7 | |||||
| Income taxes | (5.0 | ) | (6.5 | ) | |||
| Net earnings | 16.9 | % | 15.2 | % |
Three months ended March 31, 2013 compared to three months ended March 31, 2012
Net sales for the quarter ended March 31, 2013 were $737.1 million as compared to $711.1 million in the prior year quarter, an increase of 4%. The increase was the result of sales from acquisitions of 7%, and negative organic growth of 3%. Acquisitions included those completed in 2012.
In our Industrial Technology segment, net sales were down 7% to $182.2 million in the first quarter of 2013 as compared to $195.1 million in the first quarter of 2012, due primarily to the loss of a customer at our water metering business and lower sales at our materials testing business. Gross margins increased to 51.2% for the first quarter of 2013 as compared to 50.6% in the first quarter of 2012 due to product mix. Selling, general and administrative ("SG&A") expenses as a percentage of net sales increased to 22.2% in the current year quarter from 21.1% in the prior year quarter due to negative operating leverage on lower sales volume. The resulting operating profit margins were 29.1% in the first quarter of 2013 as compared to 29.5% in the first quarter of 2012.
Net sales in our Energy Systems & Controls segment decreased by 2% to $145.6 million during the first quarter of 2013 compared to $148.6 million in the first quarter of 2012. Acquisitions added 1% while organic sales decreased by 3%. The decrease in organic sales was due to lower sales in our industrial pressure sensors business. Gross margins increased to 55.6% in the first quarter of 2013, as compared to 54.1% in the first quarter of 2012 due to product mix. SG&A expenses as a percentage of net sales were 31.0% compared to 30.1% in the prior year quarter due to negative operating leverage on lower sales volume. As a result, operating margins were 24.5% in the first quarter of 2013 as compared to 24.0% in the first quarter of 2012.
Our Medical & Scientific Imaging segment net sales increased by 23% to $200.4 million in the first quarter of 2013 as compared to $162.8 million in the first quarter of 2012. Acquisitions completed in 2012 accounted for 32% of the increase, with negative organic growth of 8% due to decreased sales in our electron microscopy and imaging businesses. The foreign exchange impact was a negative 1%. Gross margins increased to 67.3% in the first quarter of 2013 from 65.2% in the first quarter of 2012 due primarily to additional sales from medical products which have a higher gross margin. SG&A expenses as a percentage of net sales were 37.4% in the first quarter of 2013 as compared to 38.6% in the first quarter of 2012 due to additional sales from medical products which have a lower fixed-cost structure. As a result, operating margins were 29.9% in the first quarter of 2013 as compared to 26.6% in the first quarter of 2012.
In our RF Technology segment, net sales were $208.8 million in the first quarter of 2013 as compared to $204.5 million in the first quarter of 2012, an increase of 2%. The increase was due primarily to growth in our toll and traffic and security solutions businesses. Gross margins increased to 53.9% as compared to 51.8% in the prior year quarter due to a more favorable product mix and operating leverage on higher sales volume. SG&A expenses as a percentage of net sales in the first quarter of 2013 decreased to 26.8% as compared to 27.2% in the prior year due to operating leverage on higher sales volume. As a result, operating profit margins were 27.1% in 2013 as compared to 24.6% in 2012.
Corporate expenses were $20.0 million, or 2.7% of sales, in the first quarter of 2013 as compared to $16.6 million, or 2.3% of sales, in the first quarter of 2012. The increase was due to higher stock-based compensation resulting from higher stock prices.
Interest expense was $20.9 million for the first quarter of 2013 as compared to $15.5 million in the first quarter of 2012. The increase was due to higher average outstanding debt balances related to 2012 acquisitions, offset in part by lower average interest rates.
Other expense increased to $2.5 million in the first quarter of 2013 as compared to $0.5 million in the first quarter of 2012 due to foreign exchange losses at our non-U.S. based subsidiaries.
Income taxes were 22.8% of pretax earnings in the current quarter, lower than the prior year rate of 29.8%. The reduction was due to $6 million in discrete tax benefits related to the enactment of the American Taxpayer Relief Act of 2012 ("ATRA"), as well as a $6 million benefit from the adjustment of tax balances which were immaterial to any covered period.
At March 31, 2013, the functional currencies of most of our European and our Canadian subsidiaries were weaker against the U.S. dollar compared to currency exchange rates at December 31, 2012. The currency changes resulted in a pretax decrease of $40 million in the foreign exchange component of comprehensive earnings for the current year quarter, $21 million of which is related to goodwill and does not directly affect our expected future cash flows. During the quarter ended March 31, 2013, the functional currencies of our Canadian and some of our European subsidiaries were weaker against the U.S. dollar as compared to the quarter ended March 31, 2012. The difference in operating profits related to foreign exchange, translated into U.S. dollars, was less than 1% for these companies in the first quarter of 2013 compared to the prior year quarter.
Net orders were $793.6 million for the quarter, 9% higher than the first quarter 2012 net order intake of $729.4 million. Our order backlog at March 31, 2013 was 17% higher as compared to March 31, 2012. Acquisitions completed in 2012 contributed 8% to the current quarter orders and 15% to the current quarter order backlog.
| Net orders booked for the three months ended March 31, | Order backlog as of March 31, | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | 2012 | 2013 | 2012 | ||||||||||
| Industrial Technology | $ | 179,807 | $ | 204,002 | $ | 126,993 | $ | 152,606 | |||||
| Energy Systems & Controls | 157,537 | 153,376 | 120,921 | 126,262 | |||||||||
| Medical & Scientific Imaging | 216,121 | 168,336 | 247,959 | 124,681 | |||||||||
| RF Technology | 240,118 | 203,672 | 501,065 | 447,085 | |||||||||
| Total | $ | 793,583 | $ | 729,386 | $ | 996,938 | $ | 850,634 |
Financial Condition, Liquidity and Capital Resources
Selected cash flows for the three months ended March 31, 2013 and 2012 were as follows (in millions):
| Three months ended March 31, | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2013 | 2012 | |||||||
| Cash provided by/(used in): | ||||||||
| Operating activities | $ | 171.3 | $ | 141.5 | ||||
| Investing activities | (13.2 | ) | (28.8 | ) | ||||
| Financing activities | (88.8 | ) | (2.3 | ) |
Operating activities - Net cash provided by operating activities increased by 21.1% to $171.3 million in the first quarter of 2013 as compared to $141.5 million in the first quarter of 2012 due to higher net earnings and increased amortization of other intangibles related to acquisitions and stock-based compensation.
Investing activities - Cash used in investing activities during the first quarter of 2013 was primarily for capital expenditures, and was primarily for business acquisitions and capital expenditures in the first quarter of 2012.
Financing activities - Cash used in financing activities in the current year quarter, and was primarily for debt principal repayments and primarily for dividends and debt principal repayments in the prior year quarter. Cash provided by financing activities in the first quarters of 2013 and 2012 was primarily from stock option proceeds. Net debt payments were $100.1 million in the three months ended March 31, 2013 as compared to $6.3 million in the three months ended March 31, 2012.
Total debt at March 31, 2013 consisted of the following (amounts in thousands):
| $500 million senior notes due 2013* | $ | 502,586 | ||
|---|---|---|---|---|
| $400 million senior notes due 2017 | 400,000 | |||
| $500 million senior notes due 2019 | 500,000 | |||
| $500 million senior notes due 2022 | 500,000 | |||
| Senior Subordinated Convertible Notes | 11,647 | |||
| Revolving Facility | - | |||
| Other | 5,540 | |||
| Total debt | 1,919,773 | |||
| Less current portion | 516,514 | |||
| Long-term debt | $ | 1,403,259 |
*Shown including fair value swap adjustment of $2,586.
The interest rate on borrowings under our $1.5 billion credit facility is calculated based upon various recognized indices plus a margin as defined in the credit agreement. At March 31, 2013, there were no outstanding borrowings under the facility. At March 31, 2013, we had $5.5 million of other debt in the form of capital leases, several smaller facilities that allow for borrowings or the issuance of letters of credit in various foreign locations to support our non-U.S. businesses and $41 million of outstanding letters of credit.
The cash and short-term investments at our foreign subsidiaries at March 31, 2013 totaled $312 million. Repatriation of these funds under current regulatory and tax law for use in domestic operations would expose us to additional taxes. We consider this cash to be permanently reinvested. We expect existing cash and cash equivalents, cash generated by our U.S. operations, our unsecured credit facility, as well as our expected ability to access the capital markets, will be sufficient to fund operating requirements in the U.S. for the foreseeable future.
We were in compliance with all debt covenants related to our credit facilities throughout the quarter ended March 31, 2013.
Net working capital (total current assets, excluding cash, less total current liabilities, excluding debt) was $288.8 million at March 31, 2013 compared to $307.8 million at December 31, 2012, reflecting decreases in working capital due primarily to improved receivables collection. Total debt was $1.92 billion at March 31, 2013 as compared to $2.02 billion at December 31, 2012, due to the use of operating cash flows to reduce outstanding debt. Our leverage is shown in the following table:
| March 31, 2013 | December 31, 2012 | |||||||
|---|---|---|---|---|---|---|---|---|
| Total Debt | $ | 1,919,773 | $ | 2,022,122 | ||||
| Cash | (430,022 | ) | (370,590 | ) | ||||
| Net Debt | 1,489,751 | 1,651,532 | ||||||
| Stockholders' Equity | 3,782,176 | 3,687,726 | ||||||
| Total Net Capital | $ | 5,271,927 | $ | 5,339,258 | ||||
| Net Debt / Total Net Capital | 28.3 | % | 30.9 | % |
At March 31, 2013, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
Capital expenditures of $11.2 million and $10.0 million were incurred during the first quarters of 2013 and 2012, respectively. We expect capital expenditures for the balance of the year to be comparable to prior years as a percentage of sales.
Outlook
Current geopolitical uncertainties could adversely affect our business prospects. A significant terrorist attack or other global conflict could cause changes in world economies that would adversely affect us. It is impossible to isolate each of these factor's effects on current economic conditions. It is also impossible to predict with any reasonable degree of certainty what or when any additional events may occur that also will similarly disrupt the economy.
We maintain an active acquisition program; however, future acquisitions will be dependent on numerous factors and it is not feasible to reasonably estimate if or when any such acquisitions will occur and what the impact will be on our business, financial condition and results of operations. Such acquisitions may be financed by the use of existing credit lines, future cash flows from operations, the proceeds from the issuance of new debt or equity securities or some combination of these methods.
We anticipate that our recently acquired companies as well as our other companies will generate positive cash flows from operating activities, and that these cash flows will permit the reduction of currently outstanding debt. However, the rate at which we can reduce our debt during 2013 (and reduce the associated interest expense) will be affected by, among other things, the financing and operating requirements of any new acquisitions and the financial performance of our existing companies; and none of these factors can be predicted with certainty.
Previous: Item 1. FINANCIAL STATEMENTS · Next: Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK